$EXPO
EXPONENT INC

2015 Q4 Form 10-Q Financial Statement

#000114420415063389 Filed on November 06, 2015

View on sec.gov

Income Statement

Concept 2015 Q4 2015 Q1 2014 Q4
Revenue $78.99M $73.61M $78.56M
YoY Change 0.56% 1.11%
Cost Of Revenue $4.500M $4.000M $4.300M
YoY Change 4.65% 8.11%
Gross Profit $74.50M $69.60M $74.30M
YoY Change 0.27% 0.87%
Gross Profit Margin 94.31% 94.55% 94.58%
Selling, General & Admin $46.80M $48.70M $48.30M
YoY Change -3.11% -2.99%
% of Gross Profit 62.82% 69.97% 65.01%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.300M $1.400M $1.400M
YoY Change -7.14% 7.69%
% of Gross Profit 1.74% 2.01% 1.88%
Operating Expenses $58.07M $55.50M $59.32M
YoY Change -2.1% -2.12%
Operating Profit $20.92M $14.13M $19.24M
YoY Change 8.75% 14.9%
Interest Expense $0.00 $0.00 $0.00
YoY Change
% of Operating Profit 0.0% 0.0% 0.0%
Other Income/Expense, Net -$2.148M $1.700M -$863.0K
YoY Change 148.9% -26.09%
Pretax Income $18.77M $15.83M $18.38M
YoY Change 2.17% 7.67%
Income Tax $7.054M $6.600M $7.335M
% Of Pretax Income 37.58% 41.7% 39.92%
Net Earnings $11.72M $9.243M $11.04M
YoY Change 6.15% 6.24%
Net Earnings / Revenue 14.84% 12.56% 14.05%
Basic Earnings Per Share $0.44 $0.35 $0.41
Diluted Earnings Per Share $0.43 $0.34 $0.40
COMMON SHARES
Basic Shares Outstanding 26.60M shares 26.59M shares 26.94M shares
Diluted Shares Outstanding 27.27M shares 27.32M shares 27.65M shares

Balance Sheet

Concept 2015 Q4 2015 Q1 2014 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $151.3M $154.4M $141.6M
YoY Change 6.85% -1.09%
Cash & Equivalents $124.5M $129.5M $44.20M
Short-Term Investments $26.80M $24.90M $26.00M
Other Short-Term Assets $24.00M $14.70M $23.70M
YoY Change 1.27% -20.97%
Inventory
Prepaid Expenses
Receivables $94.20M $86.37M $89.10M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $269.5M $266.5M $254.5M
YoY Change 5.89% 5.89%
LONG-TERM ASSETS
Property, Plant & Equipment $29.40M $28.26M $28.80M
YoY Change 2.08% -1.59%
Goodwill $8.607M
YoY Change 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $61.50M $1.121M $60.20M
YoY Change 2.16% 103.45%
Total Long-Term Assets $99.50M $98.80M $97.56M
YoY Change 1.99% 6.83%
TOTAL ASSETS
Total Short-Term Assets $269.5M $266.5M $254.5M
Total Long-Term Assets $99.50M $98.80M $97.56M
Total Assets $369.0M $365.3M $352.1M
YoY Change 4.81% 6.14%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $8.900M $2.230M $11.00M
YoY Change -19.09% -20.3%
Accrued Expenses $54.70M $6.705M $54.50M
YoY Change 0.37% 18.8%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $69.60M $79.35M $71.36M
YoY Change -2.46% 9.98%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $42.60M $1.862M $1.613M
YoY Change 2541.04% 57.66%
Total Long-Term Liabilities $42.60M $1.862M $1.613M
YoY Change 2541.04% 57.66%
TOTAL LIABILITIES
Total Short-Term Liabilities $69.60M $79.35M $71.36M
Total Long-Term Liabilities $42.60M $1.862M $1.613M
Total Liabilities $112.2M $121.0M $111.5M
YoY Change 0.62% 10.91%
SHAREHOLDERS EQUITY
Retained Earnings $247.0M $241.1M
YoY Change 9.26%
Common Stock $160.2M $158.9M
YoY Change 13.43%
Preferred Stock
YoY Change
Treasury Stock (at cost) $162.0M $159.1M
YoY Change 22.4%
Treasury Stock Shares 7.172M shares 7.111M shares 3.519M shares
Shareholders Equity $256.8M $244.3M $240.5M
YoY Change
Total Liabilities & Shareholders Equity $369.0M $365.3M $352.1M
YoY Change 4.81% 6.14%

Cashflow Statement

Concept 2015 Q4 2015 Q1 2014 Q4
OPERATING ACTIVITIES
Net Income $11.72M $9.243M $11.04M
YoY Change 6.15% 6.24%
Depreciation, Depletion And Amortization $1.300M $1.400M $1.400M
YoY Change -7.14% 7.69%
Cash From Operating Activities $19.50M $22.20M $15.40M
YoY Change 26.62% -20.71%
INVESTING ACTIVITIES
Capital Expenditures $2.641M -$1.000M $1.930M
YoY Change 36.84% -37.5%
Acquisitions
YoY Change
Other Investing Activities -$9.000M $900.0K $5.400M
YoY Change -266.67% -104.48%
Cash From Investing Activities -$11.60M -$200.0K $3.500M
YoY Change -431.43% -99.08%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -15.20M -7.500M -15.00M
YoY Change 1.33% 33.93%
NET CHANGE
Cash From Operating Activities 19.50M 22.20M 15.40M
Cash From Investing Activities -11.60M -200.0K 3.500M
Cash From Financing Activities -15.20M -7.500M -15.00M
Net Change In Cash -7.300M 14.50M 3.900M
YoY Change -287.18% 1971.43%
FREE CASH FLOW
Cash From Operating Activities $19.50M $22.20M $15.40M
Capital Expenditures $2.641M -$1.000M $1.930M
Free Cash Flow $16.86M $23.20M $13.47M
YoY Change 25.16% -21.62%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2015Q1 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
11002000 USD
CY2015Q1 us-gaap Assets Current
AssetsCurrent
266500000 USD
CY2015Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
28264000 USD
CY2015Q1 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
24612000 USD
CY2015Q1 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
36195000 USD
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
19979000 USD
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
19482000 USD
us-gaap Cost Of Reimbursable Expense
CostOfReimbursableExpense
13235000 USD
us-gaap Cost Of Reimbursable Expense
CostOfReimbursableExpense
11531000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11538000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11809000 USD
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
225916000 USD
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
219562000 USD
us-gaap Reimbursement Revenue
ReimbursementRevenue
13235000 USD
us-gaap Reimbursement Revenue
ReimbursementRevenue
11531000 USD
us-gaap Revenues
Revenues
239151000 USD
us-gaap Revenues
Revenues
231093000 USD
us-gaap Labor And Related Expense
LaborAndRelatedExpense
139745000 USD
us-gaap Labor And Related Expense
LaborAndRelatedExpense
138855000 USD
CY2014Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4363000 USD
CY2015Q1 us-gaap Goodwill
Goodwill
8607000 USD
CY2015Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
365299000 USD
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
368981000 USD
CY2015Q4 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
74503000 USD
CY2014Q4 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
74264000 USD
CY2015Q4 us-gaap Reimbursement Revenue
ReimbursementRevenue
4491000 USD
CY2014Q4 us-gaap Revenues
Revenues
78557000 USD
CY2015Q4 us-gaap Labor And Related Expense
LaborAndRelatedExpense
42853000 USD
CY2014Q4 us-gaap Labor And Related Expense
LaborAndRelatedExpense
43948000 USD
CY2015Q4 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
6766000 USD
CY2014Q4 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
6715000 USD
CY2015Q4 us-gaap Cost Of Reimbursable Expense
CostOfReimbursableExpense
4491000 USD
CY2014Q4 us-gaap Cost Of Reimbursable Expense
CostOfReimbursableExpense
4293000 USD
CY2015Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3963000 USD
CY2015Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
20921000 USD
CY2014Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
19238000 USD
CY2015Q4 us-gaap Investment Income Net
InvestmentIncomeNet
47000 USD
CY2014Q4 us-gaap Investment Income Net
InvestmentIncomeNet
33000 USD
CY2015Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1121000 USD
CY2015Q1 us-gaap Assets
Assets
365299000 USD
us-gaap Operating Expenses
OperatingExpenses
184497000 USD
CY2015Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2195000 USD
CY2014Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-896000 USD
CY2015Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
18773000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
367000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-535000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-471000 USD
CY2015Q4 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
13000 USD
CY2014Q4 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-13000 USD
CY2014Q2 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
3262000 USD
CY2014Q3 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
3270000 USD
CY2014Q4 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
3262000 USD
us-gaap Investment Income Net
InvestmentIncomeNet
115000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2605000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
49416000 USD
us-gaap Investment Income Net
InvestmentIncomeNet
117000 USD
CY2014Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
18375000 USD
CY2015Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7054000 USD
CY2014Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7335000 USD
CY2015Q4 us-gaap Net Income Loss
NetIncomeLoss
11719000 USD
CY2014Q4 us-gaap Net Income Loss
NetIncomeLoss
11040000 USD
CY2015Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.44
CY2014Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.41
CY2015Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.43
CY2014Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26938000 shares
CY2015Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27268000 shares
CY2014Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27648000 shares
CY2015Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.150
CY2014Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.125
CY2015Q4 us-gaap Operating Expenses
OperatingExpenses
58073000 USD
CY2014Q4 us-gaap Operating Expenses
OperatingExpenses
59319000 USD
CY2015Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2148000 USD
CY2014Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-863000 USD
us-gaap Operating Expenses
OperatingExpenses
181677000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
54654000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
21387000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
20680000 USD
us-gaap Net Income Loss
NetIncomeLoss
33749000 USD
us-gaap Net Income Loss
NetIncomeLoss
31458000 USD
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.27
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.16
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.23
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.13
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26644000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27018000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27350000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27778000 shares
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.450
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.375
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-4000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
9000 USD
CY2015Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
11533000 USD
CY2014Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
10187000 USD
CY2015Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
3340000 USD
CY2015Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
3386000 USD
CY2015Q2 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
3858000 USD
CY2015Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.150
CY2015Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
154380000 USD
CY2015Q4 expo Common Stock Dividends Per Share Declared Subsequent Event
CommonStockDividendsPerShareDeclaredSubsequentEvent
0.15
CY2015Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000 shares
CY2015Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
3608000 USD
CY2015Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
71729000 USD
CY2015Q4 expo Deferred Compensation Plan Liabilities Fair Value Disclosure
DeferredCompensationPlanLiabilitiesFairValueDisclosure
45038000 USD
CY2015Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
45038000 USD
CY2015Q1 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
45478000 USD
CY2015Q1 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
114239000 USD
CY2015Q1 expo Deferred Compensation Plan Liabilities Fair Value Disclosure
DeferredCompensationPlanLiabilitiesFairValueDisclosure
45394000 USD
CY2015Q1 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
45394000 USD
CY2015Q4 expo Available For Sale Securities Short Term Investments Amortized Cost Due In Year One
AvailableForSaleSecuritiesShortTermInvestmentsAmortizedCostDueInYearOne
10821000 USD
CY2015Q4 expo Available For Sale Securities Short Term Investments Amortized Cost Due In Year Two
AvailableForSaleSecuritiesShortTermInvestmentsAmortizedCostDueInYearTwo
16000000 USD
CY2015Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
26821000 USD
CY2015Q4 expo Available For Sale Securities Short Term Investments Estimated Fair Value Due In Year One
AvailableForSaleSecuritiesShortTermInvestmentsEstimatedFairValueDueInYearOne
10823000 USD
CY2015Q4 expo Available For Sale Securities Short Term Investments Estimated Fair Value Due In Year Two
AvailableForSaleSecuritiesShortTermInvestmentsEstimatedFairValueDueInYearTwo
16014000 USD
CY2015Q1 expo Available For Sale Securities Gross Unrealized Gain Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments
27000 USD
CY2015Q1 expo Available For Sale Securities Gross Unrealized Loss Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments
4000 USD
CY2015Q1 expo Cash Cash Equivalents And Short Term Investments Fair Value Disclosure
CashCashEquivalentsAndShortTermInvestmentsFairValueDisclosure
154403000 USD
CY2015Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
151278000 USD
CY2015Q4 expo Available For Sale Securities Gross Unrealized Gain Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments
17000 USD
CY2015Q4 expo Available For Sale Securities Gross Unrealized Loss Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments
1000 USD
expo Vested Restricted Stock Awards Issued To Settle Accrued Bonuses
VestedRestrictedStockAwardsIssuedToSettleAccruedBonuses
6169000 USD
CY2015Q4 expo Cash Cash Equivalents And Short Term Investments Fair Value Disclosure
CashCashEquivalentsAndShortTermInvestmentsFairValueDisclosure
151294000 USD
CY2012Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
35000000 USD
CY2013Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
35000000 USD
CY2014Q2 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
35000000 USD
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
767278 shares
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
19814000 USD
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
463402 shares
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
27923000 USD
CY2015Q4 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
15265000 USD
us-gaap Treasury Stock Reissued At Lower Than Repurchase Price
TreasuryStockReissuedAtLowerThanRepurchasePrice
4943000 USD
us-gaap Treasury Stock Reissued At Lower Than Repurchase Price
TreasuryStockReissuedAtLowerThanRepurchasePrice
6050000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
17087000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
17458000 USD
CY2015Q4 expo Entity Wide Account Receivable Major Customer Percentage
EntityWideAccountReceivableMajorCustomerPercentage
0.1 pure
CY2015Q4 us-gaap Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
10000 USD
expo Vested Restricted Stock Awards Issued To Settle Accrued Bonuses
VestedRestrictedStockAwardsIssuedToSettleAccruedBonuses
6008000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
805000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
164000 USD
CY2015Q4 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2641000 USD
CY2014Q4 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1930000 USD
CY2015Q4 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1329000 USD
CY2014Q4 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1346000 USD
CY2015Q4 expo Entity Wide Sales Revenue Major Customer
EntityWideSalesRevenueMajorCustomer
0.1 pure
CY2015Q1 us-gaap Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
14000 USD
CY2015Q4 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-1453000 USD
CY2015Q1 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-918000 USD
CY2015Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1443000 USD
CY2015Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-904000 USD
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2015Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000 shares
CY2015Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000 shares
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
32853000 shares
CY2015Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
32853000 shares
CY2015Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
7172000 shares
CY2015Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
7111000 shares
CY2015Q3 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.150
CY2015Q4 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.150
CY2015Q3 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
3887000 USD
CY2015Q4 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
3870000 USD
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
11615000 USD
CY2015Q4 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
0 USD
CY2015Q4 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2015Q4 us-gaap Goodwill Other Changes
GoodwillOtherChanges
0 USD
CY2015Q4 us-gaap Goodwill Period Increase Decrease
GoodwillPeriodIncreaseDecrease
0 USD
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
0 USD
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
us-gaap Goodwill Other Changes
GoodwillOtherChanges
0 USD
us-gaap Goodwill Period Increase Decrease
GoodwillPeriodIncreaseDecrease
0 USD
CY2015Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
3216000 USD
CY2015 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
13010000 USD
CY2014Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.125
CY2014Q3 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.125
CY2014Q4 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.125
CY2015Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.125
CY2015Q2 us-gaap Stockholders Equity Note Stock Split
StockholdersEquityNoteStockSplit
two-for-one stock split
CY2014Q4 expo Entity Wide Account Receivable Major Customer Percentage
EntityWideAccountReceivableMajorCustomerPercentage
0.1 pure
CY2015Q1 expo Entity Wide Sales Revenue Major Customer
EntityWideSalesRevenueMajorCustomer
0.1 pure
CY2015Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000 shares
expo Share Based Compensation Arrangements By Share Based Payment Award Options Expiration Term
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationTerm
P10Y
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 pure
us-gaap Liabilities Assumed1
LiabilitiesAssumed1
0 USD
us-gaap Liabilities Assumed1
LiabilitiesAssumed1
1551000 USD

Files In Submission

Name View Source Status
0001144204-15-063389-index-headers.html Edgar Link pending
0001144204-15-063389-index.html Edgar Link pending
0001144204-15-063389.txt Edgar Link pending
0001144204-15-063389-xbrl.zip Edgar Link pending
expo-20151002.xml Edgar Link completed
expo-20151002.xsd Edgar Link pending
expo-20151002_cal.xml Edgar Link unprocessable
expo-20151002_def.xml Edgar Link unprocessable
expo-20151002_lab.xml Edgar Link unprocessable
expo-20151002_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v422765_10q.htm Edgar Link pending
v422765_ex31-1.htm Edgar Link pending
v422765_ex31-2.htm Edgar Link pending
v422765_ex32-1.htm Edgar Link pending
v422765_ex32-2.htm Edgar Link pending